10 Best Biotech Stocks Under $10 to Buy

8. MeiraGTx Holdings plc (NASDAQ:MGTX)

Number of Hedge Fund Holders: 23 

Stock Price as of Last Close on April 10: $8.97

MeiraGTx Holdings plc (NASDAQ:MGTX) is one of the best biotech stocks to invest in.

TheFly reported on April 1 that Evercore ISI analyst Gavin Clark-Gartner reduced the price target on MGTX from $20 to $18 while maintaining an Outperform rating. The revision was part of a broader update across small- and mid-cap biotechnology companies tied to an assessment of upcoming second-quarter catalysts. The firm also considered longer-term developments, noting that stock performance in the sector is increasingly influenced by expectations around full-year 2026 milestones.

Earlier on March 26, MeiraGTx Holdings plc (NASDAQ:MGTX) announced that the U.S. Food and Drug Administration granted Breakthrough Therapy Designation to its AAV2-hAQP1 program for treating Grade 2 and Grade 3 late xerostomia resulting from radiotherapy in cancers of the upper aerodigestive tract.

The designation was supported by long-term data from a Phase 1 dose-escalation study demonstrating sustained outcomes. The therapy had previously received Regenerative Medicine Advanced Therapy status, further strengthening its regulatory position. The company is advancing a Phase 2 study designed to support a potential biologics license application, with data expected following completion of patient treatment and follow-up, keeping the program on track for future regulatory submission and commercialization plans.

MeiraGTx Holdings plc (NASDAQ:MGTX) is a clinical-stage biotechnology company focused on developing gene therapies for serious diseases. It leverages viral vector technologies to target genetic disorders, ocular diseases, and neurodegenerative conditions with the aim of delivering durable, transformative treatments.